Dr. Virginia Pascual, a renowned physician-scientist specializing in pediatric rheumatology, has been appointed the founding Gale and Ira Drukier Director of the Gale and Ira Drukier Institute for Children’s Health.
The natural lifecycle of cells that line the intestine is critical to preserving stable conditions in the gut, according to new research led by a Weill Cornell Medicine investigator. The findings may lead to the development of new therapies to alleviate inflammatory bowel disease (IBD) and other chronic inflammatory illnesses.
The Junior Faculty Fellowship Fund, which provides $50,000 in research support to exceptional junior faculty who are juggling basic or clinical research with childcare responsibilities, recently made awards to five Weill Cornell Medicine scientists and physicians.
A newly discovered type of genetic mutation that occurs frequently in cancer cells may provide clues about the disease’s origins and offer new therapeutic targets.
Bolstering its commitment to improving human health and increasing access to quality healthcare worldwide, Weill Cornell Medicine has entered into an agreement with Tahoe Investment Group Co. Ltd. to assist in the development of an international hospital in Shanghai, China.
Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new multicenter study from UC San Francisco, Weill Cornell Medicine and three other medical centers.
While diet, exercise and behavior modification are essential components of obesity management, a successful long-term weight loss strategy should also include avoiding or minimizing medication-related weight gain.
Dr. Christopher Barbieri was the type of kid who would press every button in the house, much to his parents’ chagrin. Ultimately he learned to put that inquisitiveness to good use as a doctor and scientist, and discovered a new form of prostate cancer.
Weill Cornell Medicine investigators have been awarded a one-year, $10,000 grant from Colleen’s Dream Foundation to define the role of a potentially crucial biomarker in the treatment of ovarian cancer tumors.
The Center for Comprehensive Spine Care takes a multidisciplinary approach to treat patients suffering from back, neck, hand and joint pain, arthritis, spinal stenosis, sciatica, rotator cuff injuries, disc injuries and carpal tunnel syndrome, among other conditions.
Dr. David Carr-Locke has been recruited as clinical director of the Center for Advanced Digestive Care at NewYork-Presbyterian/Weill Cornell Medical Center.
